BGI, Roche roll out diagnostic tests for Alzheimer's in China
Yahoo • • health
Key Points:
- BGI Genomics and Roche Diagnostics have introduced blood tests for Alzheimer's disease in China to improve diagnosis and monitoring accessibility for patients.
- BGI's blood test is currently used in several Chinese cities as a supplementary tool to assess disease progression and risk, though it is not intended as a standalone diagnostic method.
- Roche's test, which measures the Alzheimer's-related protein pTau181, has been clinically implemented in a hospital in Boao, Hainan province, and is under regulatory review for broader availability.
- These blood tests offer a less invasive and potentially faster alternative to traditional diagnostic methods like spinal taps and PET scans, facilitating earlier screening and treatment access.
- A negative result from Roche's pTau181 test can help patients avoid unnecessary
